Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Initiates Coverage On CarMax with Hold Rating

Needham analyst Chris Pierce initiates coverage on CarMax (NYSE:KMX) with a Hold rating.

byBenzinga Newsdesk

May 2, 2022

1 minute read

Needham analyst Chris Pierce initiates coverage on CarMax (NYSE:KMX) with a Hold rating.

M&A
News

Philip Morris To Buy Fertin Pharma For $820M

By Shivani Kumaresan

Today, 2:42 AM

Philip Morris International Inc (NYSE:PM) has agreed to acquire Fertin Pharma, a Denmark-based developer and manufacturer of pharmaceutical and well-being products.…

Incannex’s Cannabinoid Combo Product Reduces AHI In Sleep Apnea Patients

By Vandana Singh

Today, 2:42 AM

Incannex Healthcare Limited (NASDAQ: IXHL) has

IXHL

What Does Redwire’s Debt Look Like?

By Benzinga Insights

Today, 2:42 AM

Shares of Redwire Inc. (NYSE:RDW) increased by 85.75% in the past three months. Before having a look at…

RDW

Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference

By Maureen Meehan

Today, 2:42 AM

Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights:

AMZN

Needham Initiates Coverage On CarMax with Hold Rating

Related Posts

Philip Morris To Buy Fertin Pharma For $820M

Incannex’s Cannabinoid Combo Product Reduces AHI In Sleep Apnea Patients

What Does Redwire’s Debt Look Like?

Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference